Media interview

• 4 August 2005
  Interview With: Dr. Clive Dix, Ph.D. Chief Executive Officer
  

RealPlayer required - click here to download

Conferences sponsored by PowderMed

• 21 - 23 March 2006
  DNA Vaccination by Gene Gun - Magdalen College, Oxford

Press releases

• 1 August 2005
  Powdermed Manufactures a Vaccine Against H5n1 (Avian Influenza) for Clinical Development
  
  
• 20 February 2005
  Rolf Stahel Appointed as Chairman of PowderMed
  
  
• 18 November 2004
  Positive outcome of Phase I DNA Influenza Study - PowderMed announces first clinical trial results
  
  
• 8 November 2004
  PowderMed appoints Adam Christie as Chief Business Officer
  
  
• 16 October 2004
  PowderMed initiate a Phase I clinical trial for a novel therapeutic Herpes Simplex type 2 (HSV2) DNA vaccine
  
  
• 17 September 2004
  Ludwig Institiute for Cancer Research and PowderMed initiate a Phase I clinical trial for a novel therapeutic cancer vaccine
  
  
• 17 May 2004
  PowderMed launched in spin out of powder injection DNA vaccine programmes from Chiron Vaccines

Press materials

• Corporate factsheet (260k PDF)
  
• Japanese factsheet (940k PDF)